The role of nebulized therapy in the management of COPD: evidence and recommendations. (Q37980189)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on February 2012

Language	Label	Description	Also known as
English	The role of nebulized therapy in the management of COPD: evidence and recommendations.	scientific article published on February 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292598%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

The role of nebulized therapy in the management of COPD: evidence and recommendations (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292598%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292598%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Ruben D Restrepo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292598%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Myrna Dolovich

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292598%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Bradley Chipps

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292598%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Timothy R Myers

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292598%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Judith Rosen Farrar

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292598%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

0 references

publication date

1 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292598%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

COPD: Journal of Chronic Obstructive Pulmonary Disease

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292598%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292598%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292598%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

58-72

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22292598%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Aerosol drug delivery: developments in device design and clinical use.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Medication adherence issues in patients treated for COPD.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

What the pulmonary specialist should know about the new inhalation therapies

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Inhalation therapy in invasive and noninvasive mechanical ventilation.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysis

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Improper patient techniques with metered dose inhalers: clinical consequences and solutions to misuse.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhaler

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

The use of dry powder inhaler devices by elderly patients suffering from chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Dry powder inhalers: which factors determine the frequency of handling errors?

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Improving drug delivery from medical nebulizers: the effects of increased nebulizer flow rates and reservoirs

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

In-vitro characterisation of the nebulised dose during non-invasive ventilation

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Use of Respimat Soft Mist inhaler in COPD patients

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Results of a multicenter study of nebulized inhalant bronchodilator solutions

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Long-term safety of nebulized formoterol: results of a twelve-month open-label clinical trial

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

The safety and efficacy of arformoterol and formoterol in COPD.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Effect of nebulized arformoterol on airway function in COPD: results from two randomized trials

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Efficacy of nebulized flunisolide combined with salbutamol and ipratropium bromide in stable patients with moderate-to-severe chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

One-year treatment with mometasone furoate in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Survey of patients' views of domiciliary nebuliser treatment for chronic lung disease

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

The role of nebulized inhaled corticosteroid therapy in adult patients with asthma and chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Clinical practice. Acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Gas exchange response to short-acting beta2-agonists in chronic obstructive pulmonary disease severe exacerbations

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Addition of salmeterol to existing treatment in patients with COPD: a 12 month study

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Contemporary management of chronic obstructive pulmonary disease: scientific review

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPD

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

A respiratory therapist-directed protocol for managing inpatients with asthma and COPD incorporating a long-acting bronchodilator

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Budesonide. An updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Adverse effects of oral corticosteroids in relation to dose in patients with lung disease

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

The role of nebulised budesonide in the treatment of exacerbations of COPD.

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Inhaled flunisolide for acute severe asthma

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Compatibility of budesonide inhalation suspension with four nebulizing solutions

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Comparison of the Efficacy of Nebulised Budesonide with Parenteral Corticosteroids in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2011.630047

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37980189&oldid=1188851261"